ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 339579 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 339579; 2) Community: the network communities that were significantly associated with the response to NSC 339579; 3) Molecule: the relationships between components within communities and NSC 339579; 4) MDR: the compounds that were significantly associated with the NSC 339579.

NSC Compound Enrichment Correlation
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 3.52090010908444e-005 0.60785804
NSC 225112 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- 5.82211804338771e-005 0.8192062
NSC 404027 Null 5.88106018705558e-006 0.24124346
NSC 747292 Null 5.88106018705558e-006 0.70671798
NSC 212446 Null 5.88106018705562e-006 0.62912083
NSC 123111 Mitomycin derivative T 53 6.13985294021474e-005 0.5200103
NSC 153353 L-Alanosine 6.13985294021474e-005 0.57651853
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 6.67967536140751e-005 0.83664208
NSC 757113 METHOTREXATE(+/-) 6.74487631170136e-005 0.81237639
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 6.74487631170141e-005 0.74856509
Total:105  Current:104    [First] [Prev] [Next] [Last]